PTGX (Protagonist Therapeutics, Inc.) Sof foyda

PTGX (Protagonist) - kompaniyaning tovar belgisi

Immunologiya yetakchilari bilan qattiq raqobat Protagonist Therapeutics (PTGX) uchun jiddiy xavflarni yuzaga keltirmoqda, biroq ichak terapiyasi uchun oral peptidlarining faol ishlab chiqilishi ushbu tahdidlarni yumshatadi. Kompaniyaning haqiqiy foydasi ushbu kurashning natijasini aniq namoyish etadi, bunda 0.08 belgisi joriy rentabellik darajasini ko'rsatadi. Shu bilan birga, sanoat gigantlari bilan hamkorlik va diversifikatsiyalashgan dori portfeli ushbu biotexnologiya kompaniyasining kapitalizatsiyasini ishonchli tarzda himoya qiladi.

PTGX (Protagonist Therapeutics) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

Protagonist (PTGX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Protagonist Corp|PTGX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Protagonist Corp|PTGX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Protagonist Therapeutics|PTGX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi protagonist-inc.com|PTGX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Protagonist Therapeutics|PTGX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Protagonist Therapeutics, Inc.|PTGX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Protagonist Corp|PTGX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Protagonist Therapeutics|Shoshilinch likvidlik protagonist-inc.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
PTGX - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Protagonist Therapeutics
Protagonist Therapeutics Inc asosiy tovari

Istiqbolli emitentlarni tanlash fundamental koeffitsientlar tahliliga asoslangan bo'lib, bunda pul oqimi dinamikasi biznesning yashovchanligini belgilaydi. Kompaniyaning haqiqiy foydasini tahlil qilish orqali investor stagnatsiya davrlaridagi yashirin kapital faoliyatini aniqlaydi, bu esa klinik sinovlarning muvaffaqiyatsizligi xavfi ostida, yuqori naqd pul sarfi va J&J to'lovlariga bog'liqlik tufayli sog'liqni saqlash giganti Protagonist Therapeutics (PTGX) uchun juda muhimdir.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|IMVT (Immunovant Inc) - Yakuniy foyda|Sof foyda KNSA (Kiniksa Pharmaceuticals Ltd)|Sof moliyaviy natija Grifols Biemat (GRFS)|ADPT - Kompaniyaning sof foydasi|celldex.com (CLDX) - Sof daromad|Aurinia Pharmaceuticals Inc. (AUPH) - Kompaniyaning sof foydasi|Sof daromad BioCryst Pharmaceuticals, Inc.|Sof daromad VERA|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|PHAR - Kompaniyaning sof foydasi|Soliqdan keyingi foyda NKTR|Upstream Bio Inc (UPB) - Kompaniyaning sof foydasi|zenasbio.com - Yakuniy foyda|Kompaniyaning sof foydasi Immunome|Kompaniyaning sof daromadi Gossamer Bio Inc GOSS|Sof daromad KALV (KalVista Pharmaceuticals Inc)|Soliqlar to‘langandan keyingi foyda SEPN|Sof foyda PVLA (Pieris Pharmaceuticals)|Sof foyda savarapharma.com SVRA|Rigel Pharmaceuticals, Inc. - Sof foyda|Yillik sof foyda AnaptysBio Inc (ANAB)|Astria Pharma (ATXS) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi enGene Corp (ENGN)|Kompaniyaning sof foydasi RAPT Therapeutics, Inc.|Kompaniya foydasi JBIO (Aerovate)|Sof foyda ACRS|Sof moliyaviy natija Kyverna Therapeutics Inc.|Kompaniyaning sof foydasi Tiziana Life Sciences PLC TLSA|Sof moliyaviy natija Cabaletta Bio Inc (CABA)|VTYX: Sof daromad|theratech.com - Soliqlar to‘langandan keyingi foyda|AVTX (Avalo Therapeutics) - Sof daromad|Eledon Pharmaceuticals Inc. - Yakuniy foyda|Sof daromad AGEN|CLYM (Climb Bio, Inc) - Soliqlar to‘langandan keyingi foyda|Sof foyda ZURA|ATYR (atyrpharma.com) - Yakuniy foyda|Sof foyda ADAG (Adagene Inc.)|ImageneBio (IMA) - Kompaniyaning sof daromadi|STTK - Kompaniyaning sof foydasi|Yakuniy foyda EQ (Equillium, Inc.)|CNTB: Sof foyda|Immunic (IMUX) - Sof foyda|Kompaniyaning sof foydasi Atara Biotherapeutics, Inc.|InflaRx GmbH - Soliqdan keyingi foyda|Sof foyda XFOR|ACET - Kompaniyaning sof daromadi|Celularity - Sof daromad|Sof foyda inmunebio.com INMB|BRNS: Sof daromad|Kezar Life Sciences Inc. - Soliqlar to‘langandan keyingi foyda|SABS: Sof foyda|AKTX - Sof moliyaviy natija|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Sof daromad Q32 Bio Corp (QTTB)|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof moliyaviy natija Edesa Biotech Inc|Kompaniyaning sof foydasi iBio Corp IBIO|CARM (Carisma Therapeutics Inc) - Soliqdan keyingi foyda|XTLB: Sof daromad|Bolt Biotherapeutics - Soliqlar to‘langandan keyingi foyda|HCWB: Sof foyda|Yillik sof foyda Aptevo Therapeutics Inc. APVO|Sof daromad AIM|Kompaniya foydasi ADTX (Aditxt Corp)|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|XRTX: Soliqdan keyingi foyda|Sof foyda HIND (Vyome Holdings)|Yakuniy foyda REVB|Indaptus - Sof foyda|SCNI - Sof foyda|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Affimed N.V. - Yakuniy foyda|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Sof foyda IGMS|Sof foyda iTeos Pharma (ITOS)|Ocean Biomedical, Inc. - Sof daromad|Yakuniy foyda TCBP|Third Harmonic Bio, Inc. - Sof foyda